GEMTAZ INFUSMART 1.6GM INJECTION

GEMTAZ INFUSMART 1.6GM INJECTION affects cancer cells more than healthy cells because cancer cells have a higher rate of DNA synthesis and replication than healthy cells. GEMTAZ INFUSMART 1.6GM INJECTION interferes with this process, which is essential for cancer cell growth and division, ultimately leading to the death of cancer cells.

No, GEMTAZ INFUSMART 1.6GM INJECTION is not recommended for adolescents and children under the age of 18.

Patients should inform their doctor of any pre-existing medical conditions, allergies, or medications they are taking before starting GEMTAZ INFUSMART 1.6GM INJECTION treatment. It is also important to inform the doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Patients may need to make dietary or lifestyle changes while taking GEMTAZ INFUSMART 1.6GM INJECTION, such as avoiding certain foods or activities that may interfere with the medication's effectiveness or cause side effects. This should be discussed with a healthcare professional.

GEMTAZ INFUSMART 1.6GM INJECTION can help slow the growth and spread of cancer cells, but it may not cure cancer on its own. It is often used in combination with other treatments, such as surgery, radiation therapy, or other chemotherapy medications, to improve the chances of a cure or long-term remission.

The duration of GEMTAZ INFUSMART 1.6GM INJECTION treatment will depend on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication. Treatment may last several weeks or months.

It is not recommended if you are allergic to Gemcitabine. Your doctor may monitor blood counts, sugar, electrolytes, liver, and kidney functions regularly.

Yes, it may impair fertility in men. Men are advised not to father children during treatment and for 6 months after. Both men and women should use contraception during and for 6 months after the last dose.

The active ingredient is GEMCITABINE.

It is used to slow down the growth and spread of cancer cells.

It is typically given as an intravenous infusion by a healthcare professional.

It is often used in combination with surgery, radiation therapy, or other chemotherapy.

Its effectiveness depends on the specific type and stage of cancer. Your doctor will determine if it is suitable for your condition.